The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Bavarian Nordic’s Vimkunya (recombinant, adsorbed ...

The options are for the freeze-dried version of Bavarian Nordic’s Jynneos, a formulation that allows easier stockpiling.

The freeze-dried formulation will be easier to store and transport than the liquid-frozen formulation that Bavarian Nordic ...

Exercised options total USD 143.6 million; Secures manufacturing and supply of freeze-dried JYNNEOS ® to the U.S. in 2026; COPENHAGEN, Denmark, May 6, 2025 – Bavarian Nordic A/ ...

Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has ...

Get Bavarian Nordic A/S alerts: Bavarian Nordic A/S (OTCMKTS:BVNRY – Get Free Report) last issued its quarterly earnings data on Wednesday, March 5th. The company reported $0.47 earnings per ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Copenhagen, Denmark Saturday, May 3, 2025, 12:00 Hrs [IST] ...